Key result
First-generation immigrant status linked to ~36% higher risk of confirmed disease worsening vs. Swedish-born individuals.
Why the study?
Multiple sclerosis displays geographic and ethnic variation, but the contribution of migration status and region of origin to long-term outcomes remains uncertain.
Does migration status and region of origin impact long-term disability, cognitive, and patient-reported outcomes in individuals with multiple sclerosis?
Case-Control (n=4,008)
Yes
Does migration status and region of origin impact long-term disability, cognitive, and patient-reported outcomes in individuals with multiple sclerosis?
Effect estimate: HR 1.36 (95% CI 1.18 to 1.56)
First-generation immigrants and individuals of MENA origin with multiple sclerosis in Sweden experience faster disability progression, highlighting the need for early risk stratification and culturally adapted care.
May warrant early risk stratification and culturally adapted MS care in immigrants; extends evidence on migration as determinant of disability progression.
Background Multiple sclerosis (MS) shows marked geographic and ethnic variation, but the contribution of migration status and region of origin to long-term outcomes remains uncertain. We aimed to examine disability, cognitive and patient-reported outcomes across these dimensions. Methods We analysed 4008 individuals with incident relapsing-onset MS from two nationwide Swedish case-control studies (2005–2019), with registry-based follow-up through April 2022. Repeated measures of expanded disability status scale (EDSS), symbol digit modalities test (SDMT) and MS impact scale (MSIS-29) were obtained prospectively. Cox regression compared outcomes by migration status (Swedish-born with Swedish parents, first-generation immigrants, Swedish-born with immigrant parent/s) and region of origin (Sweden, Nordic countries, non-Nordic Europe, Middle East and North Africa (MENA) and other). Results Compared with Swedish-born individuals with Swedish parents, first-generation immigrants had higher risks of confirmed disease worsening (CDW) (HR 1.36, 95% CI 1.18 to 1.56) and reaching EDSS 3 (HR 1.25, 95% CI 1.03 to 1.52), whereas Swedish-born individuals with immigrant parents did not differ from the reference group. By region of origin, participants of MENA origin had higher risks of CDW (HR 1.45, 95% CI 1.15 to 1.82), EDSS 3 (HR 1.46, 95% CI 1.07 to 2.00), EDSS 4 (HR 1.82, 95% CI 1.19 to 2.80), SDMT worsening (HR 1.79, 95% CI 1.26 to 2.51) and MSIS-29 worsening. Conclusions Within a universal-access health system, first-generation immigration into Sweden was associated with faster disability progression, and MENA origin showed consistent excess risks across disability, cognitive and patient-reported outcomes. The overall pattern points to a combination of migration-related and origin-linked influences on MS progression, supporting early risk stratification and culturally adapted care strategies.
No takes yet. Share an insight, caveat, or question.
Hedström et al. (2026) conducted a case-control in incident relapsing-onset MS (n=4,008). First-generation immigration vs. Swedish-born individuals with Swedish parents was evaluated on confirmed disease worsening (CDW) (HR 1.36, 95% CI 1.18 to 1.56). First-generation immigrants to Sweden had a higher risk of confirmed disease worsening compared with Swedish-born individuals with Swedish parents (HR 1.36; 95% CI 1.18-1.56).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: